ORIC Pharmaceuticals, Inc. Stock Börse Stuttgart
Equities
4TZ
US68622P1093
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.05 EUR | 0.00% | -11.88% | -13.50% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 505M 472M |
---|---|---|---|---|---|
Net income 2024 * | -114M -106M | Net income 2025 * | -138M -129M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.35
x | P/E ratio 2025 * |
-3.88
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.45% |
Latest transcript on ORIC Pharmaceuticals, Inc.
1 week | -11.88% | ||
Current month | -15.57% | ||
1 month | -15.06% | ||
3 months | -49.28% | ||
6 months | -16.07% | ||
Current year | -13.50% |
Managers | Title | Age | Since |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 18-05-06 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Director of Finance/CFO | 50 | 19-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 21-11-08 |
Richard Heyman
FOU | Founder | 66 | 13-12-31 |
Mardi Dier
BRD | Director/Board Member | 60 | 20-03-01 |
Date | Price | Change |
---|---|---|
24-06-14 | 7.05 | 0.00% |
24-06-13 | 7.05 | -4.08% |
24-06-12 | 7.35 | -1.34% |
24-06-11 | 7.45 | -5.10% |
24-06-10 | 7.85 | -1.88% |
Delayed Quote Börse Stuttgart, June 14, 2024 at 02:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- ORIC Stock
- 4TZ Stock